- Home
- OP vs KLTO Comparison
OP vs KLTO Comparison
Compare OP & KLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OP
- KLTO
- Stock Information
- Founded
- OP 2021
- KLTO 2019
- Country
- OP Greece
- KLTO United States
- Employees
- OP N/A
- KLTO N/A
- Industry
- OP
- KLTO
- Sector
- OP
- KLTO
- Exchange
- OP Nasdaq
- KLTO NYSE
- Market Cap
- OP 5.3M
- KLTO 4.8M
- IPO Year
- OP N/A
- KLTO N/A
- Fundamental
- Price
- OP $0.82
- KLTO $0.22
- Analyst Decision
- OP
- KLTO
- Analyst Count
- OP 0
- KLTO 0
- Target Price
- OP N/A
- KLTO N/A
- AVG Volume (30 Days)
- OP 33.8K
- KLTO 31.8M
- Earning Date
- OP 06-05-2025
- KLTO 05-15-2025
- Dividend Yield
- OP N/A
- KLTO N/A
- EPS Growth
- OP N/A
- KLTO N/A
- EPS
- OP N/A
- KLTO N/A
- Revenue
- OP $25,702,000.00
- KLTO N/A
- Revenue This Year
- OP N/A
- KLTO N/A
- Revenue Next Year
- OP N/A
- KLTO N/A
- P/E Ratio
- OP N/A
- KLTO N/A
- Revenue Growth
- OP 35.58
- KLTO N/A
- 52 Week Low
- OP $0.63
- KLTO $0.11
- 52 Week High
- OP $2.71
- KLTO $13.10
- Technical
- Relative Strength Index (RSI)
- OP 61.64
- KLTO N/A
- Support Level
- OP $0.65
- KLTO N/A
- Resistance Level
- OP $0.75
- KLTO N/A
- Average True Range (ATR)
- OP 0.05
- KLTO 0.00
- MACD
- OP 0.02
- KLTO 0.00
- Stochastic Oscillator
- OP 99.94
- KLTO 0.00
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.